Captrust Financial Advisors Myriad Genetics Inc Put Options Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
246Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$262 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$174 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$143 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$95.2 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$76.1 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.4B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...